SCHEMBL8080681

SCHEMBL8080681

CC(OC(=O)c1ccccc1)Oc1ccc(C(=O)c2c(-c3ccc(O)cc3)sc3cc(O)ccc23)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 18/20 0.58
ESR2 Q92731 10/20 0.55
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
CNR1 P21554 2/20 0.50
PLD2 O14939 1/20 0.50
KDM1A O60341 1/20 0.50
NR1I2 O75469 1/20 0.50
USP2 O75604 1/20 0.50
ALDH1A1 P00352 1/20 0.50
C5 P01031 1/20 0.50
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50
FYN P06241 1/20 0.50
PGR P06401 1/20 0.50
CYP3A4 P08684 1/20 0.50
ADRA2A P08913 1/20 0.50
ADORA3 P0DMS8 1/20 0.50
CYP2D6 P10635 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8072899 0.88 CNR1 (0.61) ESR1ESR2TDP1CNR1CNR2
SCHEMBL14559000 0.84 ESR1 (0.70) ESR1ESR2MEN1KMT2ATDP1
SCHEMBL8082455 0.83 ESR1 (0.61) ESR1ESR2MEN1KMT2ATDP1
SCHEMBL7107598 0.82 ESR1 (0.75) ESR1ESR2MEN1KMT2ATDP1
SCHEMBL11550840 0.81 CNR1 (0.71) ESR1ESR2MEN1KMT2ATDP1
SCHEMBL11552368 0.79 ESR1 (0.75) ESR1ESR2MEN1KMT2ATDP1
SCHEMBL8080684 0.79 ESR1 (0.64) ESR1ESR2MEN1KMT2ATDP1
SCHEMBL11552941 0.79 CNR1 (0.71) ESR1ESR2MEN1KMT2ATDP1
SCHEMBL11546554 0.79 CNR1 (0.67) ESR1ESR2TDP1CNR1ALDH1A1
SCHEMBL7075664 0.79 ESR1 (0.74) ESR1ESR2MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6090843-A POSTMENOPAUSE DISEASES; ESTROGEN SENSITIVITY; BONE DISORDERS ELI LILLY AND COMPANY (US) 2000-07-18 US claimed
EP-0902025-A2 Benzothiophenes for treatment of estrogen related conditions ELI LILLY AND COMPANY (US) 1999-03-17 EP claimed
US-6090843-A POSTMENOPAUSE DISEASES; ESTROGEN SENSITIVITY; BONE DISORDERS ELI LILLY AND COMPANY (US) 2000-07-18 US disclosed